UK Contraceptive Devices Market-Market Dynamics
The report details several factors driving and restraining the market, some of which are listed below.
Increasing incidence of STDs
Increasing government initiatives for abortion
Increasing awareness amongst people
Infertility issues and fear or experience of side-effects are factors turning out to be restraints to this market.
The UK's contraceptive devices market has been segmented based on contraceptive methods, mode of delivery and type of device. The segmentation on contraceptive methods has been subdivided into sterilization, pills, implants, injectables, IUD, male condoms, vaginal barrier methods and others. The segmentation based on the mode of delivery has been sub-divided into oral contraceptives, topical contraceptives, and contraceptive injectables. The segmentation based on the type of device has been sub-divided into condoms, diaphragms, cervical caps, sponges, vaginal rings, IUD, and implants.
The intrauterine devices (IUD) segment has the largest market share in the UK. There is also a sustained growth of sub-dermal implants in the UK's market.
Market definition along with identification of key drivers and restraints for the market.
Market analysis for the UK's contraceptive devices market, with region-specific assessments and competition analysis.
Identification of factors instrumental in changing the market scenario, rising prospective opportunities and identification of key companies that can influence the market.
Extensively researched competitive landscape section with profiles of major companies along with their strategic initiatives and market share.
Identification and analysis of the macro and micro factors that affect the UK's contraceptive devices market on a regional scale.
A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information
1.1 Study Deliverables
1.2 Market Definition
1.3 Sizing Units
1.4 Base Currency
1.5 Review and Forecast Period Years
1.6 General Study Assumptions
2. Research Methodology
2.2 Analysis Methodology
2.3 Econometric Forecast Model
2.4 Research Assumptions
3. Executive Summary
4. Key Inferences
5. Market Overview and Industry Trends
5.1 Current Market Scenario
5.2 Contraceptive Devices Applications
5.3 Technology Overview
5.4 New Developments
5.5 Industry Value Chain Analysis
5.6 Product Life Cycle Analysis
5.7 Product Benchmarking
5.8 Investment Analysis
5.9 Porter's Five Forces
5.9.1 Bargaining Power of Suppliers
5.9.2 Bargaining Power of Consumers
5.9.3 Threat to New Entrants
5.9.4 Threat to Substitute Products and Services
5.9.5 Competitive Rivalry within the Industry
6. Drivers, Restraints, Opportunities, and Challenges Analysis
6.1 Market Drivers
6.1.1 Product Innovation
6.1.2 Increasing Incidence of STDs
6.1.3 Pregnancy Prevention
6.1.4 Increasing Government Initiatives for Unwanted Abortion
6.1.5 Increasing Awareness amongst People
6.2 Market Restraints
6.2.1 Infertility Issues
6.2.2 Fear or Experience of Side Effects
7. UK Contraceptive Devices Market Segmentation
7.2 By Contraceptive Methods
7.2.5 Intrauterine Device
7.2.6 Male Condoms
7.2.7 Vaginal Barrier Methods
7.3 By Mode of Delivery
7.3.1 Oral Contraceptives
220.127.116.11 Combined Oral Contraceptive Pills
18.104.22.168 Progestin-Only Pill
22.214.171.124 Emergency Contraceptive Pill
7.3.2 Topical Contraceptives
7.3.3 Contraceptive Injectables
7.4 By Type of Device
7.4.3 Cervical Caps
7.4.5 Vaginal Rings
8. Market Segmentation by Geography - the UK
8.2 United Kingdom Market
9. Competitive Landscape
9.1 Merger and Acquisition Analysis
9.2 New Product Launches
9.3 Agreements, Collaborations, and Partnerships
10. Key Vendor Analysis
10.1 Church & Dwight, Co. Inc.
10.2 Reckitt Benckiser PLC
10.3 Bayer healthcare
10.4 Teva Pharmaceuticals
10.6 Fuji Latex
10.7 Actavis Inc.
10.8 Merck & Co. Inc.
10.9 Agile Therapeutics
11. Analyst Outlook for Investment Opportunities
12. Future Outlook of the Market